Silva, S., Duarte, J., Simão, C. and Felizardo, M. (2025) “Osimertinib: A Game-Changer in Stage IV EGFR-Driven Lung Cancer”, Acta Médica Portuguesa. Lisbon, Portugal, 38(9), pp. 568–572. doi: 10.20344/amp.22031.